By Bright Kobby Nsakyi

Modern chemotherapy is a miracle of science, transforming once-fatal cancers into manageable conditions. But as survival rates climb, a hidden cost is emerging: the very drugs saving patients’ lives are sometimes damaging their hearts. This side effect, known as chemotherapy-induced cardiotoxicity, has quietly made cardiovascular disease a leading threat to long-term cancer survivors.

As Dr. Javid Moslehi, a pioneering researcher in cardio-oncology, has emphasized, the ultimate goal of cancer care is ensuring that a patient survives both the cancer and the cardiovascular consequences of the treatment.

The “Symptomatic Gap”

Currently, the standard way to monitor a patient’s heart during treatment relies on imaging tools—like an echocardiogram—to measure pumping function. The problem? By the time a machine detects a drop in function, the heart has usually already sustained significant damage.

Yet, patients often sense something is wrong long before a scan confirms it; they might experience extreme exhaustion, shortness of breath, or palpitations. Researchers call this the “symptomatic gap”: the critical space between what a patient feels in their daily life and what clinical tests can actually measure. According to guidelines from the European Society of Cardiology, early detection of this toxicity is paramount, as the structural damage caused by many regimens is often cumulative and difficult to reverse once advanced.

How Different Treatments Impact the Heart

Chemotherapy medications don’t all affect the cardiovascular system in the exact same way. Rather than causing a single type of problem, different classes of cancer drugs target distinct parts of the heart and circulatory system:

Heart Muscle Damage: Some drugs cause direct wear and tear on the heart muscle itself. As the muscle weakens over time, patients may experience deep exhaustion or struggle to catch their breath during light everyday tasks.

Blood Vessel Injury: Other medications irritate or damage the lining of blood vessels. This can lead to sudden spikes in blood pressure, reduced blood flow, blood clots, or unexpected chest pain.

Electrical Rhythm Disruption: Certain treatments interfere with the body’s natural electrical signals that regulate the heartbeat. This can cause the heart to race, pound, or skip beats, often leaving patients feeling dizzy or lightheaded.

A Simple, Powerful Solution

The good news is that we don’t always need expensive equipment to catch heart issues early. By routinely asking patients simple questions about how they feel—using a structured symptom checklist—doctors can spot the early signs of heart trouble.

The American College of Cardiology increasingly champions this approach, noting that integrating patient-reported outcomes into routine care is a crucial step in bridging the disconnect between clinical imaging and lived experience. In healthcare settings where advanced heart scans aren’t always easily available, empowering patients to report their symptoms could be a highly effective, low-cost game-changer. Ultimately, protecting a cancer survivor’s heart might start with simply listening to what they have to say.